These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 2702117

  • 1. Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?
    Bakker WW, van Luijk WH.
    Pediatr Nephrol; 1989 Jul; 3(3):341-9. PubMed ID: 2702117
    [Abstract] [Full Text] [Related]

  • 2. Studies of vascular permeability factor derived from T lymphocytes and inhibitory effect of plasma on its production in minimal change nephrotic syndrome.
    Tomizawa S, Maruyama K, Nagasawa N, Suzuki S, Kuroume T.
    Nephron; 1985 Jul; 41(2):157-60. PubMed ID: 3876517
    [Abstract] [Full Text] [Related]

  • 3. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Cho MH, Hong EH, Lee TH, Ko CW.
    Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
    [Abstract] [Full Text] [Related]

  • 4. [Minimal change nephrotic syndrome].
    Uda S, Nakayama T, Hirose M, Yoshimura A.
    Nihon Rinsho; 2004 Oct; 62(10):1829-36. PubMed ID: 15500126
    [Abstract] [Full Text] [Related]

  • 5. [Minimal change nephrotic syndrome : new insights into disease pathogenesis].
    Audard V, Lang P, Sahali D.
    Med Sci (Paris); 2008 Oct; 24(10):853-8. PubMed ID: 18950582
    [Abstract] [Full Text] [Related]

  • 6. T-cell subpopulations in childhood nephrotic syndrome.
    Kobayashi K, Yoshikawa N, Nakamura H.
    Clin Nephrol; 1994 May; 41(5):253-8. PubMed ID: 8050203
    [Abstract] [Full Text] [Related]

  • 7. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Kitano Y, Yoshikawa N, Nakamura H.
    Clin Nephrol; 1993 Oct; 40(4):199-204. PubMed ID: 8261675
    [Abstract] [Full Text] [Related]

  • 8. Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome.
    Yoshizawa N, Kusumi Y, Matsumoto K, Oshima S, Takeuchi A, Kawamura O, Kubota T, Kondo S, Niwa H.
    Nephron; 1989 Oct; 51(3):370-6. PubMed ID: 2918948
    [Abstract] [Full Text] [Related]

  • 9. Pattern of interleukins in minimal-change nephrotic syndrome of childhood.
    Saxena S, Mittal A, Andal A.
    Nephron; 1993 Oct; 65(1):56-61. PubMed ID: 8413792
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K, Kanmatsuse K.
    Nephron; 2001 Feb; 87(2):111-7. PubMed ID: 11244304
    [Abstract] [Full Text] [Related]

  • 11. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
    Matsumoto K, Kanmatsuse K.
    Clin Nephrol; 2001 Apr; 55(4):269-74. PubMed ID: 11334311
    [Abstract] [Full Text] [Related]

  • 12. Immunological profile in children with minimal change nephrotic syndrome.
    Gupta S, Yuceoglu AM.
    Acta Paediatr Scand; 1985 Sep; 74(5):726-32. PubMed ID: 2931943
    [Abstract] [Full Text] [Related]

  • 13. Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms.
    Cara-Fuentes G, Clapp WL, Johnson RJ, Garin EH.
    Pediatr Nephrol; 2016 Dec; 31(12):2179-2189. PubMed ID: 27384691
    [Abstract] [Full Text] [Related]

  • 14. Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease.
    Aggarwal N, Batwara R, McCarthy ET, Sharma R, Sharma M, Savin VJ.
    Am J Kidney Dis; 2007 Nov; 50(5):826-9. PubMed ID: 17954296
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
    Matsumoto K, Kanmatsuse K.
    Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
    [Abstract] [Full Text] [Related]

  • 16. A case of Guillain-Barré syndrome developed minimal change nephrotic syndrome simultaneously.
    Kitamura H, Nakano T, Kakihara M, Nishino M, Isshiki K, Kawano K, Yamauchi A, Imai E, Kamada T, Abe H.
    Am J Nephrol; 1998 Jul; 18(2):151-4. PubMed ID: 9569959
    [Abstract] [Full Text] [Related]

  • 17. Vascular permeability increasing factor (VPF) in IgA nephropathy.
    Bakker WW, Beukhof JR, van Luijk WH, van der Hem GK.
    Clin Nephrol; 1982 Oct; 18(4):165-7. PubMed ID: 7140031
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
    Okuyama S, Komatsuda A, Wakui H, Aiba N, Fujishima N, Iwamoto K, Ohtani H, Sawada K.
    Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
    [Abstract] [Full Text] [Related]

  • 19. Minimal-change nephrotic syndrome associated with systemic lupus erythematosus.
    Makino H, Haramoto T, Shikata K, Ogura T, Ota Z.
    Am J Nephrol; 1995 Mar; 15(5):439-41. PubMed ID: 7503146
    [Abstract] [Full Text] [Related]

  • 20. Significance of mesangial IgA deposition in minimal change nephrotic syndrome: a study of 60 cases.
    Choi J, Jeong HJ, Lee HY, Kim PK, Lee JS, Han DS.
    Yonsei Med J; 1990 Sep; 31(3):258-63. PubMed ID: 2281685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.